Trillium Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Trillium Therapeutics Stock Forecast and Price Target
If the average price target of C$26.91 set by distinguished experts for Trillium Therapeutics over the past few weeks is reached this year, there would be a potential upside of approximately 15.3% from the last closing price in November, 2021. This potential increase is based on a high estimate of C$30.14 and a low estimate of C$23.95. Even if you're not interested in TRIL stock, you may be interested in its competitors.
15.30% Upside
Trillium Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Trillium Therapeutics's Price has increased by 100.00%, going from C$0.00 to C$0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach C$25.11 – an increase of 100.00%. The Trillium Therapeutics forecast is for Fair Value to reach C$47.46 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$167.29 | Buy/Sell | $178.42 | 12.98% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$269.38 | Buy/Sell | $303.65 | 17.77% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$65.27 | Buy/Sell | $87.82 | 22.57% |
| ALXN Stock Forecast | Alexion Pharmaceuticals | - |
0
|
$182.50 | Buy/Sell | $177.38 | -100.00% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$202.46 | Buy/Sell | $299.62 | 42.50% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMRN Stock Forecast | BioMarin Pharmaceutical | Outperform |
10
|
$82.17 | Buy/Sell | $111.56 | 33.87% |
| INCY Stock Forecast | Incyte | Outperform |
9
|
$51.18 | Buy/Sell | $77.05 | 50.84% |
| VKTX Stock Forecast | Viking Therapeutics | Buy |
5
|
$68.86 | Buy/Sell | $34.00 | 67.01% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ARNA Stock Forecast | Arena Pharmaceuticals | - |
6
|
$99.99 | Buy/Sell | $100.00 | -100.00% |
| BPMC Stock Forecast | Blueprint Medicines | Outperform |
6
|
$90.73 | Buy/Sell | $85.71 | 10.22% |
| FOLD Stock Forecast | Amicus Therapeutics | Outperform |
7
|
$10.17 | Buy/Sell | $17.90 | 96.66% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CCXI Stock Forecast | ChemoCentryx | - |
8
|
$51.99 | Buy/Sell | $52.00 | -100.00% |
| CBAY Stock Forecast | CymaBay Therapeutics | - |
8
|
$32.44 | Buy/Sell | $27.73 | -100.00% |
| IOVA Stock Forecast | Iovance Biotherapeutics | Buy |
4
|
$11.54 | Buy/Sell | $20.42 | 120.97% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DRNA Stock Forecast | Dicerna Pharmaceuticals | - |
7
|
$38.01 | Buy/Sell | $35.06 | -100.00% |
| ACAD Stock Forecast | ACADIA Pharmaceuticals | Outperform |
6
|
$16.31 | Buy/Sell | $33.78 | 83.94% |
| ARWR Stock Forecast | Arrowhead Pharmaceuticals | Outperform |
7
|
$21.87 | Buy/Sell | $52.00 | 142.34% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CLDX Stock Forecast | Celldex Therapeutics | Buy |
11
|
$36.26 | Buy/Sell | $63.29 | 112.36% |
| VCEL Stock Forecast | Vericel | Buy |
8
|
$45.45 | Buy/Sell | $42.58 | 21.01% |
| ARDX Stock Forecast | Ardelyx | Buy |
11
|
$6.31 | Buy/Sell | $9.94 | 121.87% |
Trillium Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Trillium Therapeutics's EPS has increased by 100.00%, going from C$0.00 to C$0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach C$0.00 – an increase of 100.00%. The Trillium Therapeutics forecast is for EPS to reach C$0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DVAX Stock Forecast | Dynavax Technologies | Outperform |
11
|
$11.17 | Buy/Sell | $25.00 | 119.34% |
| AGIO Stock Forecast | Agios Pharmaceuticals | Outperform |
9
|
$31.67 | Buy/Sell | $40.00 | 37.35% |
| ADMA Stock Forecast | ADMA Biologics | Buy |
9
|
$6.44 | Buy/Sell | $6.00 | 24.22% |
Site Navigation
.jpg)